Strong Buy
Average AnalystStrong Buy
Top AnalystBullish
Stock Target AdvisorStrong Buy
Average UserUSD 12.67
-0.50 (-3.80%)
USD 0.01B
0.51M
USD 30.75(+142.70%)
Based on the Tyra Biosciences Inc stock forecast from 6 analysts, the average analyst target price for Tyra Biosciences Inc is USD 30.75 over the next 12 months. Tyra Biosciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Tyra Biosciences Inc is Bullish , which is based on 5 positive signals and 1 negative signals. At the last closing, Tyra Biosciences Inc’s stock price was USD 12.67. Tyra Biosciences Inc’s stock price has changed by -12.38% over the past week, -20.56% over the past month and -29.61% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company had negative total free cash flow in the most recent four quarters.